Tobacco Centers of Regulatory Science

FDA and [NIH](https://prevention.nih.gov/tobacco-regulatory-science-program), as part of an on-going interagency partnership, awarded seven Tobacco Centers of Regulatory Science (TCORS) grants in September 2023 to support research to inform the regulation of tobacco products. In this third round of funding, the TCORS 3.0 research centers will receive, in total, approximately $140 million in grants from FY 2023-2027. What scientists learn about tobacco through the TCORS program helps inform and assess FDA's ongoing and potential regulatory activities. TCORS investigators also have the flexibility and capacity to respond to FDA's research needs as issues are raised in today's rapidly evolving tobacco marketplace. **Investing in Tobacco Regulatory Science** The TCORS 3.0 program is designed to generate scientific evidence in eight scientific domains: - Understanding **tobacco product composition and design** - Approaches that test the **toxicity** of non-cigarette tobacco smoke, aerosol, or specific constituents - Effects of tobacco product characteristics on **addiction** and abuse liability - Short- and long- term **health effects** of tobacco products - Understanding of knowledge, attitudes and **behaviors** related to tobacco product use - Understanding how to effectively **communicate** the health effects of tobacco products - Influences of tobacco **marketing** - Understanding of the **impact** of potential or actual FDA regulatory actions